Literature DB >> 9770529

Overexpression of DNA polymerase beta in cell results in a mutator phenotype and a decreased sensitivity to anticancer drugs.

Y Canitrot1, C Cazaux, M Fréchet, K Bouayadi, C Lesca, B Salles, J S Hoffmann.   

Abstract

DNA polymerase beta (pol beta) is the most error prone of all known eukaryotic DNA polymerases tested in vitro. Here, we show that cells overexpressing pol beta cDNA have acquired a spontaneous mutator phenotype. By measuring the appearance of mutational events using three independent assays, we found that genetic instability increased in the cell lines that overexpressed pol beta. In addition, these cells displayed a decreased sensitivity to cancer chemotherapeutic, bifunctional, DNA-damaging agents such as cisplatin, melphalan, and mechlorethamine, resulting in enhanced mutagenesis compared with control cells. By using cell-free extracts and modified DNA substrates, we present data in support of error-prone translesion replication as one of the key determinants of tolerance phenotype. These results have implications for the potential role of pol beta overexpression in cancer predisposition and tumor progression during chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9770529      PMCID: PMC22874          DOI: 10.1073/pnas.95.21.12586

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

Review 1.  Mutator phenotype may be required for multistage carcinogenesis.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

2.  Characterization of DNA polymerase beta mRNA: cell-cycle and growth response in cultured human cells.

Authors:  B Z Zmudzka; A Fornace; J Collins; S H Wilson
Journal:  Nucleic Acids Res       Date:  1988-10-25       Impact factor: 16.971

3.  Induction of beta-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells.

Authors:  A J Fornace; B Zmudzka; M C Hollander; S H Wilson
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

Review 4.  Differential gene expression in human cancer cells resistant to cisplatin.

Authors:  K J Scanlon; M Kashani-Sabet; H Miyachi
Journal:  Cancer Invest       Date:  1989       Impact factor: 2.176

5.  DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene.

Authors:  J S Hoffmann; M J Pillaire; G Maga; V Podust; U Hübscher; G Villani
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

Review 6.  Cell cycle control and cancer.

Authors:  L H Hartwell; M B Kastan
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

7.  The design of a new mutation model for active genes: expression of the Escherichia coli lac operon in mammalian cells.

Authors:  P P van Sloun; P H Lohman; H Vrieling
Journal:  Mutat Res       Date:  1997-09       Impact factor: 2.433

8.  Mutations of mitotic checkpoint genes in human cancers.

Authors:  D P Cahill; C Lengauer; J Yu; G J Riggins; J K Willson; S D Markowitz; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 9.  Is cisplatin a human carcinogen?

Authors:  M H Greene
Journal:  J Natl Cancer Inst       Date:  1992-03-04       Impact factor: 13.506

10.  Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.

Authors:  E L Mamenta; E E Poma; W K Kaufmann; D A Delmastro; H L Grady; S G Chaney
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

View more
  54 in total

1.  Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin.

Authors:  Kriste A Lewis; Kia K Lilly; Evelyn A Reynolds; William P Sullivan; Scott H Kaufmann; William A Cliby
Journal:  Mol Cancer Ther       Date:  2009-04       Impact factor: 6.261

2.  Aag-initiated base excision repair drives alkylation-induced retinal degeneration in mice.

Authors:  Lisiane B Meira; Catherine A Moroski-Erkul; Stephanie L Green; Jennifer A Calvo; Roderick T Bronson; Dharini Shah; Leona D Samson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

3.  DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma.

Authors:  Min Li; Wenqiao Zang; Yuanyuan Wang; Yuebai Li; Yunyun Ma; Na Wang; Yue Tang; Lulu Liu; Ziming Dong; Guoqiang Zhao
Journal:  Tumour Biol       Date:  2013-06-08

4.  Characterization of DNA polymerase beta splicing variants in gastric cancer: the most frequent exon 2-deleted isoform is a non-coding RNA.

Authors:  Valeria Simonelli; Mariarosaria D'Errico; Domenico Palli; Rajendra Prasad; Samuel H Wilson; Eugenia Dogliotti
Journal:  Mutat Res       Date:  2009-07-25       Impact factor: 2.433

5.  Mutagenic Replication of the Major Oxidative Adenine Lesion 7,8-Dihydro-8-oxoadenine by Human DNA Polymerases.

Authors:  Myong-Chul Koag; Hunmin Jung; Seongmin Lee
Journal:  J Am Chem Soc       Date:  2019-03-07       Impact factor: 15.419

6.  DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability.

Authors:  Fanny Lemée; Valérie Bergoglio; Anne Fernandez-Vidal; Alice Machado-Silva; Marie-Jeanne Pillaire; Anne Bieth; Catherine Gentil; Lee Baker; Anne-Laure Martin; Claire Leduc; Elena Lam; Eddy Magdeleine; Thomas Filleron; Naïma Oumouhou; Bernd Kaina; Mineaki Seki; Fanny Grimal; Magali Lacroix-Triki; Alastair Thompson; Henri Roché; Jean-Christophe Bourdon; Richard D Wood; Jean-Sébastien Hoffmann; Christophe Cazaux
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

7.  DNA polymerase beta promoter mutations affect gene transcription, translation and the sensitivity of esophageal cancer cells to cisplatin treatment.

Authors:  Tao Wang; Wenqiao Zang; Yunyun Ma; Min Li; Xiaoyan Xuan; Na Wang; Rui Wu; Yuebai Li; Ziming Dong; Guoqiang Zhao
Journal:  Mol Biol Rep       Date:  2012-11-03       Impact factor: 2.316

8.  Spontaneous hepatocellular carcinoma is reduced in transgenic mice overexpressing human O6- methylguanine-DNA methyltransferase.

Authors:  Z Q Zhou; D Manguino; K Kewitt; G W Intano; C A McMahan; D C Herbert; M Hanes; R Reddick; Y Ikeno; C A Walter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features.

Authors:  Vinod K Batra; David D Shock; Rajendra Prasad; William A Beard; Esther W Hou; Lars C Pedersen; Jane M Sayer; Haruhiko Yagi; Subodh Kumar; Donald M Jerina; Samuel H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-01       Impact factor: 11.205

10.  Characterization of a natural mutator variant of human DNA polymerase lambda which promotes chromosomal instability by compromising NHEJ.

Authors:  Gloria Terrados; Jean-Pascal Capp; Yvan Canitrot; Miguel García-Díaz; Katarzyna Bebenek; Tomas Kirchhoff; Alberto Villanueva; François Boudsocq; Valérie Bergoglio; Christophe Cazaux; Thomas A Kunkel; Jean-Sébastien Hoffmann; Luis Blanco
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.